Latest Interviews
Showing 1501–1515 of 3,003 transcripts.
Clear all filters- a16z41 min
What's Next for the Internet?
Chris Dixon, Jonah Peretti, Jenna
Chris outlines a trajectory from centralized, ad-driven web eras to a future "Era 3" where blockchain technology restores community ownership and aligns user incentives with platform governance. He argues that this transition, analogous to the automobile industry's early 1915 stage, leverages the convergence of AI, VR, and mobile commerce to disrupt traditional finance, healthcare, and media models like BuzzFeed's shift to transactional revenue. Ultimately, the discussion posits that decentralized networks will replace extractive surveillance capitalism with meritocratic, commons-based economies, resolving the friction between private connection and public reach while sparking new regulatory battles over encryption and information control.
- Milken Institute56 min
Resilient Communities, Successful Disaster Recovery
Lynn Goldman, Elizabeth Disco-Shearer, Nancy Knight, Robert Ottenhoff, Umair A. Shah, John Balbus
This panel unites CDC officials, Harris County Public Health leaders, and philanthropic experts to address the critical "invisibility crisis" where preventative public health work remains unrecognized until disasters strike. Drawing on funding allocations like the CDC's $620 million in emergency preparedness and the disproportionate 10% of philanthropic dollars given to mitigation, the speakers argue that the current reactive funding model fails to address long-term health and economic vulnerabilities exposed by events such as the 2024 California wildfires. To counter these systemic gaps, the discussion calls for a strategic shift toward human capital resilience and sustained investment in pre-existing social vulnerabilities to ensure communities can withstand climate-driven extremes.
- a16z35 min
Scaling Creativity with Marc Andreessen and Shonda Rimes
Shonda Rhimes' Shondaland operates as a global mini-studio managing a $350 million annual production slate across five simultaneous shows, leveraging a decade of network experience to pivot toward Netflix's creative freedom and binge-model distribution. This strategic shift replaces traditional commercial constraints with narrative complexity while the organization scales through a trusted infrastructure that promotes internal talent and prioritizes work ethic over pedigree. The company maintains a 100% success rate in producing long-running series by balancing deep character development with operational autonomy, positioning itself to define the next era of writer-driven storytelling in the streaming landscape.
- Milken Institute58 min
Poised to Break the Bank: Paying for Chronic Disease
Allison Aubrey, Nancy Brown, Thomas Davis, Anand Parekh, Eric, Michael Golinkoff, John Rother, Megan Golden, Jess Leifer, Stephanie Cousins
Geisinger Health's pilot food pharmacy program demonstrated that high-intensity nutritional support significantly lowers chronic disease costs and improves patient outcomes, prompting federal interest through the 2018 Farm Bill despite scalability challenges. While experts advocate for integrated payment models and preventive policies like sugar taxes to address widespread chronic conditions, systemic barriers including data fragmentation, misaligned pharmaceutical incentives, and insufficient medical education continue to hinder broad adoption. Successful scaling now requires multi-payer collaboration to align financial incentives and address interconnected mental health and pain management needs that frequently undermine lifestyle interventions.
- Milken Institute57 min
Turning Back Time: The Science of Aging
Joanne Kenen, Nir Barzilai, Howard Fillit, Christopher Hite, Joan Mannick, Joanne Cannon, Sami, Aditi Ramdurai, San, Sarah Locke
A panel of experts led by Nir Barzilai, Christopher Healy, Howard Federoff, and Joan Manik is advocating for a paradigm shift in geroscience from treating individual chronic conditions to targeting the underlying biology of aging. The group is pursuing "healthspan compression" through concrete initiatives like the TAME metformin trial, TORC1 inhibitor development, and combination therapies designed to delay multiple diseases simultaneously. While regulatory hurdles and ethical concerns regarding long-term drug use remain, these efforts aim to prove that extending healthy life is economically viable and socially transformative.
- Jane Street50 min
Michael Sikorski: Dude, Where Are My Files? Reverse Engineering Ransomware
FireEye malware analyst Michael Sikorski details the escalating threat landscape of financially motivated ransomware, highlighting catastrophic real-world impacts on organizations like Maersk and the shift of state actors toward direct extortion. He outlines essential analysis methodologies, ranging from static binary examination to deep reverse engineering, which revealed critical kill switches for devastating strains such as WannaCry and the destructive EternalPetya attack. Ultimately, the presentation emphasizes how these technical insights drive the industry's response to complex encryption schemes and enable data recovery assessments or containment measures against rapidly evolving malicious code.
- a16z13 min
Product Zeitgeist Fit and the Next Big Thing
This event argues that startup failure stems from user and investor indifference rather than technical limitations, proposing "Product Zeitgeist Fit" as the critical driver for success. It demonstrates how products like cryptocurrency and clean meat leverage prevailing cultural moods to attract talent and capital despite functional flaws, using diagnostic tests such as the "Nerd Heat" and "Despite" tests to identify these opportunities. Ultimately, the presentation asserts that disruptive innovation thrives by capitalizing on generational reactions to societal excesses rather than merely achieving superior product-market functionality.
- Goldman Sachs31 min
Tom Brokaw, Author of "The Fall of Richard Nixon: A Reporter Remembers Watergate"
In a new memoir, journalist Tom Brokaw chronicles the Watergate scandal and President Nixon's 1974 resignation, emphasizing how the "California crew's" hubris and efficient control systems led to the unprecedented imprisonment of Nixon's top aides. Brokaw details the methodical, cross-party investigation led by Peter Rodino and Bill Cohen, which utilized limited 1970s news cycles to dismantle Nixon's claims of executive privilege and result in a landmark Supreme Court ruling. The narrative also explores Brokaw's personal career trajectory, including his refusal of a White House offer from Haldeman and his later coverage of the Berlin Wall's fall, framing these events through the lens of journalistic integrity and the dangers of unchecked political power.
- Milken Institute1h 0m
Opioid Addiction: A Crisis Fueled by Stigma
Sarah Karlin-Smith, Kelly Clark, Gary Mendell, Andrey Ostrovsky, Nora Volkow, Ronnie Solomon, Michael Golinkoff
A panel of leading experts, including Dr. Kelly Clark and Gary Mendel, identifies deep-seated stigma as a primary driver of the opioid crisis that obstructs effective funding and policy implementation. To combat this, organizations like Shatterproof propose a seven-point strategy shifting addiction from a criminal justice issue to a chronic disease model, while researchers in Rhode Island demonstrate that medication access for released inmates drastically reduces overdose mortality. Despite these clinical victories, persistent structural barriers such as the X-waiver requirement, inadequate federal budget allocations, and restrictive privacy laws continue to hinder widespread adoption of evidence-based treatments.
- Milken Institute1h 16m
Reducing the Cost and Risk of Dementia
Nora Super, Michael Belleville, Jennie Chin Hansen, Kevin Crain, Jeff Huber, Shari Ling, Sarah Locke, Ian Cramer, Orion, Alan Stevens, Jill Lesser
Leading health officials, financial institutions, and advocacy groups are collaborating to address the rising dementia crisis through CMS payment reforms, specialized geriatric emergency departments, and early detection strategies integrated into banking and home care services. Key initiatives include the ET3 transport model, the expansion of accredited GED facilities, and Bank of America's training of financial advisors to identify cognitive decline, all aimed at shifting from reactive treatment to proactive management. Despite these systemic efforts, significant barriers such as workforce shortages, late-stage diagnoses, and caregiver burnout remain critical challenges that require continued policy innovation and community engagement to resolve.
- Milken Institute57 min
Making Influenza History: The Quest for a Universal Vaccine
Michael Specter, Rick Bright, Anthony Fauci, Bruce Gellin, Margaret Hamburg, Casey Wright
Annual seasonal influenza causes approximately 650,000 global deaths and imposes a $36.1 billion economic burden in the United States alone, yet current egg-based production methods and fragmented research efforts hinder the development of a universal vaccine. Although advances in structure-based design and synthetic mRNA technologies offer pathways to stabilize conserved viral targets and eliminate annual vaccination, commercial disincentives and outdated regulatory frameworks continue to stall progress. To overcome these systemic barriers, experts advocate for a dedicated global entity and sustained funding initiatives, such as a proposed $1 billion legislative package, to coordinate interdisciplinary collaboration and de-risk the shift toward rapid-response, long-lasting immunization platforms.
- Milken Institute1h 0m
Flipping the Script: Designing the System to Deliver for Patients
Annie Kennedy, Gigi Hirsch, Marcus Schabacker, Andy Schmeltz, Jeffrey Shuren, Marcus Wilson
Leaders from patient advocacy groups, regulators, and industry convened to address critical misalignments between regulatory data standards, payer requirements, and patient outcomes, driving a shift toward patient-led research and value-based care models. Through collaborative frameworks like FDA's Patient and Caregiver Connection and MIT's learning health systems, stakeholders are overcoming data fragmentation by integrating real-world evidence into device approvals and reimbursement decisions. This collective effort establishes a new paradigm where patient preferences directly influence benefit-risk assessments, ensuring medical innovations effectively reach the right patients at the right time while promoting equitable access.
- a16z21 min
AI is Industrializing Discovery
The speaker characterizes the current biotech era as an industrial revolution where AI is transforming drug discovery from a bespoke artisanal model into a scalable, engineering-driven process. By overcoming myths regarding biological complexity and data scarcity through techniques like graph convolutions and one-shot learning, companies are achieving accuracy rates of over 90% in biomarker discovery and predicting clinical outcomes with modest incremental gains. This strategic shift promises to slash manufacturing costs for protein therapeutics by up to 90% and reduce trial expenses, creating a critical opportunity for professionals to merge domain expertise with AI skills to industrialize discovery at unprecedented scale.
- Goldman Sachs18 min
Ethan Brown, Founder and CEO of Beyond Meat
Founder Ethan Brown directs Beyond Meat's mission to replace animal protein with plant-based alternatives that simultaneously address human health, climate change, and resource conservation. The company leverages proprietary extrusion technology and strategic retail expansion to secure partnerships with major chains like McDonald's and Subway while aiming to become a global leader rivaling Tyson and JBS. Supported by high-profile athlete endorsements and data showing up to 99% reduction in water and land usage, Beyond Meat is actively scaling its operations into Asian and European markets to drive a cultural shift toward sustainable eating.
- Goldman Sachs25 min
Episode 140: Why Startups Shouldn’t All Be Pitched As “Tech Companies”
Jake Siewert, Gregg Lemkau, Brynn Putnam, Ryan Petersen
At the Goldman Sachs Builders and Innovators Conference, over 100 global entrepreneurs, including Mirror CEO Bryn Putnam and Flexport COO Ryan Peterson, presented strategies for scaling high-growth businesses in an investment climate focused on total addressable market and long-term profitability. Putnam outlined Mirror's pivot toward a SaaS and media valuation model to diversify beyond hardware, while Peterson detailed Flexport's transition from aggressive expansion to unit economics profitability within the sclerotic global logistics sector. Participants and panelists emphasized that future success depends on rigorous fundraising discipline, the ability to navigate complex regulatory environments, and a founder mindset driven by market frustration rather than wealth accumulation.